Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. Sjögren
Safety and Efficacy of Six Months' Open Label Extension Post-RCT Using the Novel Cathepsin K Inhibitor MIV-711 in Patients With Knee Osteoarthritis
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Related publications
Nonclinical and Clinical Pharmacological Characterization of the Potent and Selective Cathepsin K Inhibitor MIV-711
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
SAT0236 Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral Jak-1 Inhibitor in Patients With Rheumatoid Arthritis in an Open Label Extension Study
Erratum To: Efficacy and Safety of Piascledine 300 Versus Chondroitin Sulfate in a 6 Months Treatment Plus 2 Months Observation in Patients With Osteoarthritis of the Knee
Clinical Rheumatology
Medicine
Rheumatology
Assessment of Efficacy and Safety of “Chondroxid” Gel in Comparison With “Finalgel" in Patients With Knee Osteoarthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Use of ARTRA MSM FORTE in Patients With Knee Osteoarthritis: Results of a Randomized Open-Label Comparative Study of the Efficacy and Tolerability of the Drug
Terapevticheskii Arkhiv
Internal Medicine
Endocrinology
Metabolism
Diabetes
Therapeutic Effectiveness and Safety of Mesotherapy in Patients With Osteoarthritis of the Knee
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders
Journal of Ayurveda Medical Sciences
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
